arrow
Back
H

Hidenori Toyoda

Ogaki Municipal Hospital

75H-index
781Paper Count
2.7WCitation Count
Published Papers 421
Publication Date
IgA-Enriched Phenotype Predicts Liver-Related Events in MASLD
err2026-07-15
err0
PREAI
errTakefumi Kimura; Shun-ichi Wakabayashi; Takanobu Iwadare; Shohei Kondo; Taiki Okumura; Hiroyuki Kobayashi; Yuki Yamashita; Yuma Kamijo; Kaede Fujita; Tomoyuki Nakajima; Takuro Uchida; Tomoo Yamazaki; Mai Iwaya; Takeshi Uehara; Hidenori Toyoda; Takashi Kumada; Takeji Umemura; Naoki Tanaka
errShare
errSave
Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic Regions
err2026-06-08
err0
errOAAI
errHidenori Toyoda; Yujin Hoshida; Neehar D. Parikh; Prasun K. Jalal; Federico Piñero; Manuel Mendizabal; Ezequiel Ridruejo; Hugo Cheinquer; Andrea Casadei-Gardini; Mounika Kanneganti; Arndt Weinmann; Markus Peck-Radosavljevic; Jean-Francois Dufour; Pompilia Radu; Gamal Shiha; Riham Soliman; Shiv K. Sarin; Manoj Kumar; Jing-Houng Wang; Pisit Tangkijvanich; Wattana Sukeepaisarnjaroen; Masanori Atsukawa; Haruki Uojima; Akito Nozaki; Makoto Nakamuta; Koichi Takaguchi; Atsushi Hiraoka; Hiroshi Abe; Kentaro Matsuura; Tsunamasa Watanabe; Noritomo Shimada; Kunihiko Tsuji; Toru Ishikawa; Shigeru Mikami; Ei Itobayashi; Philip J. Johnson; Amit G. Singal
errShare
errSave
Letter: Does Serum HBV RNA Add Incremental Value for Hepatocellular Carcinoma Risk Stratification Beyond Established Predictors? Authors' Reply
err2026-05-12
err0
errOAAI
errTakashi Kumada; Hidenori Toyoda; Satoshi Yasuda; Yuichi Koshiyama; Takanori Ito; Tomoyuki Akita; Junko Tanaka
errShare
errSave
Ablation-Based Salvage Strategy at Disease Progression After Initial Disease Control With Atezolizumab/Bevacizumab in Hepatocellular Carcinoma
err2026-05-11
err0
PREAI
errKazuya Kariyama; Kazuhiro Nouso; Atsushi Hiraoka; Fujimasa Tada; Hideko Ohama; Hidenori Toyoda; Satoshi Yasuda; Toshifumi Tada; Kazunari Tanaka; Kunihiko Tsuji; Ei Itobayashi; Akemi Tsutsui; Koichi Takaguchi; Michitaka Imai; Toru Ishikawa; Takeshi Hatanaka; Yuki Kanayama; Satoru Kakizaki; Atsushi Naganuma; Yoshihide Ueda; Tomomitsu Matono; Hideyuki Tamai; Junpei Okamura; Hironori Tanaka; Yutaka Yata; Akiko Wakuta; Masatoshi Kudo; Takashi Kumada
errShare
errSave
Superior Efficacy of Tenofovir Alafenamide Compared With Entecavir in Reducing Hepatitis B Surface Antigen: A Multicentre Propensity Score-Matched Study Using Linear Mixed-Effects Models
err2026-05-04
err0
PREAI
errTakashi Kumada; Masanori Atsukawa; Norio Itokawa; Taeang Arai; Hidenori Toyoda; Akihito Tsubota; Tsunamasa Watanabe; Makoto Chuma; Kentaro Matsuura; Atsushi Hiraoka; Toshifumi Tada; Koichi Takaguchi; Keizo Kato; Hiroshi Abe; Joji Tani; Toru Ishikawa; Chikara Ogawa; Toru Asano; Tsunekazu Oikawa; Yoshihiro Matsumoto; Tomoyuki Akita; Junko Tanaka
errShare
errSave
Diagnostic Impact of Two-Dimensional Shear Wave Elastography for Liver Fibrosis: A Multicenter Retrospective Study
err2026-05-01
err0
errOAAI
errTakashi Nishimura; Toshifumi Tada; Yasuaki Suzuki; Kento Imajo; Katsutoshi Sugimoto; Sadanobu Ogawa; Hidenori Toyoda; Tamami Abe; Hidekatsu Kuroda; Masashi Hirooka; Asako Nogami; Satoshi Oeda; Hirokazu Takahashi; Tomoyuki Akita; Reiichiro Kondo; Takuma Nakatsuka; Ryosuke Tateishi; Yoichi Hiasa; Yuichiro Eguchi; Atsushi Nakajima; Hirohisa Yano; Shigehiro Kokubu; Junko Tanaka; Fuminori Moriyasu; Masayoshi Kage; Takashi Kumada; Hiroko Iijima
errShare
errSave
Clinical Characteristics, Predictive Factors, and the Impact of Antithrombotic Therapy on Bleeding Events in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
err2026-04-21
err0
PREAI
errFujimasa Tada; Atsushi Hiraoka; Hideko Ohama; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-life Practice Experts for HCC (RELPEC) Study Group and hepatocellular carcinoma experts from 48 clinics in Japan (HCC 48) Group
errShare
errSave
Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab
err2026-04-10
err0
PREAI
errKazunari Tanaka; Kunihiko Tsuji; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Fujimasa Tada; Hideko Ohama; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-Life Practice Experts for HCC (RELPEC) Study Group and Hepatocellular Carcinoma Experts From 48 Clinics in Japan (HCC 48) Group
errShare
errSave
Comparative diagnostic performance of ultrasound-guided attenuation parameter versus B-mode scoring for hepatic steatosis assessment: an ordinal-scale statistical approach
err2026-04-02
err0
PREAI
errTakashi Kumada; Hidenori Toyoda; Sadanobu Ogawa; Tatsuya Gotoh; Yasuaki Suzuki; Kento Imajo; Masato Yoneda; Katsutoshi Sugimoto; Hidekatsu Kuroda; Nobuharu Tamaki; Masayuki Kurosaki; Tomoyuki Akita; Junko Tanaka; Atsushi Nakajima
errShare
errSave
Lymphocyte–Monocyte Ratio Predicts the Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab
err2026-02-26
err0
PREAI
errTomomitsu Matono; Toshifumi Tada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Takashi Nishimura; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Hideyuki Tamai; Shohei Komatsu; Takanori Matsuura; Yoshihide Ueda; Soo Ki Kim; Hideko Ohama; Fujimasa Tada; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Shinya Fukunishi; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Jumpei Okamura; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the RELPEC Group and HCC 48 Group
errShare
errSave
Prognostic Value of an Early Response to Tolvaptan and Its Clinical Implications in Patients With Cirrhosis and Hepatic Edema: A Nationwide Multicenter Cohort Study
err2026-02-07
err0
errOAAI
errKaori Koyano; Taeang Arai; Hidenori Toyoda; Keizo Kato; Joji Tani; Suguru Ogura; Tomomi Okubo; Korenobu Hayama; Norio Itokawa; Toshifumi Tada; Akito Nozaki; Atsushi Hiraoka; Kentaro Matsuura; Toru Ishikawa; Naoto Kawabe; Tsunamasa Watanabe; Koichi Takaguchi; Asahiro Morishita; Hironao Okubo; Motoh Iwasa; Hiroki Nishikawa; Yasuhito Tanaka; Masanori Atsukawa
errShare
errSave
Direct comparison of ultrasound-guided attenuation parameter and controlled attenuation parameter for steatosis using MRI-based proton density fat fraction as a reference
err2026-01-01
err2
PREAI
errImajo, Kento; Toyoda, Hidenori; Yasuda, Satoshi; Kuroda, Hidekatsu; Yoneda, Masato; Nakajima, Atsushi; Kumada, Takashi
errShare
errSave
Utility of Biomarker Panels in the Surveillance and Monitoring of Hepatocellular Carcinoma: Consensus Statements from an International Delphi Panel
err2025-12-01
err0
errOAAI
errSingal, Amit G.; Toyoda, Hidenori; Tanwandee, Tawesak; Tangkijvanich, Pisit; Tan, Chee-Kiat; Cua, Ian Homer; Alcantara-Payawal, Diana; Su, Tung-Hung; Huy, Nguyen Dinh Song; Yamada, Hiroyuki; Kudo, Masatoshi
errShare
errSave
Hepatitis B Virus RNA Predicts Hepatocellular Carcinoma Despite Viral Suppression
err2025-12-01
err1
PREAI
errKumada, Takashi; Toyoda, Hidenori; Yasuda, Satoshi; Koshiyama, Yuichi; Ito, Takanori; Akita, Tomoyuki; Tanaka, Junko
errShare
errSave
Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: results of the DT-real study
err2025-11-20
err0
errOAAI
errCiro Celsa; Tiziana Pressiani; Naoshi Nishida; Shadi Mohamad Chamseddine; Ashwini Arvind; Michael Li; Marta Fortuny; Najib Ben Khaled; Massimo Iavarone; Hidenori Toyoda; Ilario Giovanni Rapposelli; Andrea Casadei-Gardini; Caterina Vivaldi; Susanna Ulahannan; Haripriya Andanamala; Bernhard Scheiner; Matthias Pinter; Elena Orlandi; Claudia A.M. Fulgenzi; Giulia F. Manfredi
errShare
errSave
Comparison between vibration-controlled transient elastography and point shear wave elastography for assessment of hepatic fibrosis based on magnetic resonance elastography
err2025-11-01
err0
PREAI
errGotoh, Tatsuya; Kumada, Takashi; Ogawa, Sadanobu; Niwa, Fumihiko; Toyoda, Hidenori; Akita, Tomoyuki; Tanaka, Junko; Shimizu, Masahito
errShare
errSave
Evolution of Hepatocellular Carcinoma Treatment Outcomes Over Two Decades in Japan: Improvements in Early-Stage Viral Disease
err2025-11-01
err0
errOAAI
errKariyama, Kazuya; Nouso, Kazuhiro; Hiraoka, Atsushi; Tada, Fujimasa; Ohama, Hideko; Toyoda, Hidenori; Yasuda, Satoshi; Tada, Toshifumi; Tanaka, Kazunari; Tsuji, Kunihiko; Itobayashi, Ei; Tsutsui, Akemi; Takaguchi, Koichi; Imai, Michitaka; Ishikawa, Toru; Hatanaka, Takeshi; Kakizaki, Satoru; Naganuma, Atsushi; Ueda, Yoshihide; Matono, Tomomitsu; Tamai, Hideyuki; Okamura, Junpei; Tanaka, Hironori; Yata, Yutaka; Wakuta, Akiko; Kudo, Masatoshi; Kumada, Takashi
errShare
errSave
Identification of high-risk group for diabetes-associated hepatocellular carcinoma using noninvasive test for liver fibrosis
err2025-11-01
err0
PREAI
errKariyama, Kazuya; Nouso, Kazuhiro; Hiraoka, Atsushi; Toyoda, Hidenori; Tada, Toshifumi; Tsuji, Kunihiko; Ishikawa, Toru; Hatanaka, Takeshi; Itobayashi, Ei; Takaguchi, Koichi; Tsutsui, Akemi; Naganuma, Atsushi; Yasuda, Satoshi; Kakizaki, Satoru; Tada, Fujimasa; Ohama, Hideko; Wakuta, Akiko; Shiota, Shohei; Kumada, Takashi
errShare
errSave
Usefulness of the Fibrosis-3 index in patients with hepatitis C
err2025-11-01
err0
PREAI
errKariyama, Kazuya; Toyoda, Hidenori; Kumada, Takashi; Yasuda, Satoshi; Shiota, Shohei; Wakuta, Akiko; Nouso, Kazuhiro
errShare
errSave